US Stock MarketDetailed Quotes

CRBP Corbus Pharmaceuticals

Watchlist

17.0350
+0.2750+1.64%

Trading Nov 19 12:36 ET

207.48MMarket Cap-3616P/E (TTM)

Corbus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Corbus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Corbus Pharmaceuticals Earnings Reports

Corbus Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 7 17:08 ET

Corbus Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 6 16:44 ET

Corbus Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

May 7 16:40 ET

Corbus Pharmaceuticals | 10-K/A: Annual report (Amendment)

Mar 20 17:13 ET

Analyst Rating

Updated: Nov 19, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall